Stuart Ryan 
Medical and Clinical Manager, Roche NZ, Auckland, NZ

After receiving his PhD in 1995, Stuart worked briefly as a research scientist at HortResearch in the field of protein biochemistry. Fisher and Paykel Healthcare provided an opportunity to develop skills in applied research within a commercial environment and eventually the chance to lead a clinical research team and manage a global, medical device trial portfolio. 

In 2004 he was made General Manager of the Centre for Clinical Research and effective practice (CCRep), an independent research trust established to grow research capability at Middlemore Hospital in South Auckland. Becoming NZ’s leading DHB-based research centre, CCRep then led the establishment of the Middlemore Tumour Tissue Bank in 2010, a facility which is now governed by the University of Auckland. 

Currently, Medical and Clinical Manager at Roche NZ, Stuart manages the Clinical Operations team while also maintaining oversight and medical responsibility for the Roche portfolio of strategic oncology products.



Pharma Research - How Pharma Companies Scope for Clinical Trials

Successful execution of Pharma clinical trials, on time and on budget, is the cornerstone of bringing pipeline medicines to market. The Roche Pharma Development Group (PDG) operates a global infrastructure dedicated to generating the clinical data required to meet the requirements of regulators in key markets. New Zealand continues to attract industry-sponsored clinical trials but the expectations for NZ sites to meet tight timelines and deliver predictable performance is higher than ever. In this presentation you will get some insight into the factors that determine whether Roche clinical trials are placed in NZ and how using ‘big data’ helps Roche NZ to select trial-specific sites and investigators.